80 related articles for article (PubMed ID: 21920122)
1. Overdose with HAART: are we managing these patients adequately?
Gabler T; Yudelowitz B; Mahomed A
S Afr Med J; 2011 Jul; 101(8):520-1. PubMed ID: 21920122
[TBL] [Abstract][Full Text] [Related]
2. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
5. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
[TBL] [Abstract][Full Text] [Related]
6. HIV-infection and modern antiretroviral therapy impair sperm quality.
Kehl S; Weigel M; Müller D; Gentili M; Hornemann A; Sütterlin M
Arch Gynecol Obstet; 2011 Jul; 284(1):229-33. PubMed ID: 21448708
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
Manfredi R
Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
11. Changes in antioxidant profile among HIV-infected individuals on generic highly active antiretroviral therapy in southern India.
Sundaram M; Saghayam S; Priya B; Venkatesh KK; Balakrishnan P; Shankar EM; Murugavel KG; Solomon S; Kumarasamy N
Int J Infect Dis; 2008 Nov; 12(6):e61-6. PubMed ID: 18621564
[TBL] [Abstract][Full Text] [Related]
12. Lessons learned from use of highly active antiretroviral therapy in Africa.
Akileswaran C; Lurie MN; Flanigan TP; Mayer KH
Clin Infect Dis; 2005 Aug; 41(3):376-85. PubMed ID: 16007536
[TBL] [Abstract][Full Text] [Related]
13. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
[TBL] [Abstract][Full Text] [Related]
14. [Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso].
Millogo A; Lankoandé D; Yaméogo I; Yaméogo AA; Sawadogo AB
Bull Soc Pathol Exot; 2008 Feb; 101(1):11-3. PubMed ID: 18431998
[TBL] [Abstract][Full Text] [Related]
15. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
17. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
18. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
[TBL] [Abstract][Full Text] [Related]
19. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
